High-Dose Recombinant Interleukin 2 in the Treatment of Patients With Disseminated Cancer: Responses, Treatment-Related Morbidity, and Histologic Findings

Michael T. Lotze, Alfred E. Chang, Claudia A. Seipp, Colleen Simpson, John T. Vetto, Steven A. Rosenberg

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'High-Dose Recombinant Interleukin 2 in the Treatment of Patients With Disseminated Cancer: Responses, Treatment-Related Morbidity, and Histologic Findings'. Together they form a unique fingerprint.

Medicine & Life Sciences